1176 related articles for article (PubMed ID: 22025739)
1. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
6. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
7. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
8. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
9. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
11. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS.
Assaf Y; Chapman J; Ben-Bashat D; Hendler T; Segev Y; Korczyn AD; Graif M; Cohen Y
Magn Reson Imaging; 2005 Jul; 23(6):703-10. PubMed ID: 16198825
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
13. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
14. Eccentric development of Balo's concentric sclerosis: detected by magnetic resonance diffusion-weighted imaging and magnetic resonance spectroscopy.
Chen F; Liu T; Li J; Xing Z; Huang S; Wen G; Lu G
Int J Neurosci; 2015 Jun; 125(6):433-40. PubMed ID: 25051427
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy and diffusion tensor imaging in coma survivors: promises and pitfalls.
Tshibanda L; Vanhaudenhuyse A; Galanaud D; Boly M; Laureys S; Puybasset L
Prog Brain Res; 2009; 177():215-29. PubMed ID: 19818904
[TBL] [Abstract][Full Text] [Related]
16. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Cianfoni A; Niku S; Imbesi SG
AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
18. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
19. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
20. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
